News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
168,480 Results
Type
Article (31872)
Company Profile (12)
Press Release (136596)
Section
Business (52068)
Career Advice (362)
Deals (3217)
Drug Delivery (7)
Drug Development (23969)
Employer Resources (32)
FDA (3330)
Job Trends (3181)
News (80547)
Policy (4169)
Tag
Academia (2398)
Alliances (10780)
Alzheimer's disease (471)
Approvals (3318)
Artificial intelligence (26)
Bankruptcy (18)
Best Places to Work (2658)
Breast cancer (34)
Cancer (265)
Cardiovascular disease (21)
Career advice (333)
Cell therapy (51)
Clinical research (18117)
Collaboration (74)
COVID-19 (1164)
C-suite (59)
Data (298)
Diabetes (26)
Diagnostics (1619)
Earnings (6085)
Employer resources (29)
Events (17131)
Executive appointments (175)
FDA (3417)
Funding (77)
Gene editing (16)
Gene therapy (39)
GLP-1 (118)
Government (939)
Healthcare (5044)
Infectious disease (1179)
Inflammatory bowel disease (30)
Interviews (40)
IPO (1446)
Job creations (575)
Job search strategy (312)
Layoffs (29)
Legal (682)
Liver cancer (17)
Lung cancer (40)
Manufacturing (18)
Medical device (3008)
Medtech (3009)
Mergers & acquisitions (1782)
Metabolic disorders (72)
Neuroscience (527)
NextGen Class of 2024 (1797)
Non-profit (1704)
Northern California (345)
Obesity (33)
Opinion (26)
Parkinson's disease (17)
People (31677)
Phase I (5746)
Phase II (8327)
Phase III (5497)
Pipeline (57)
Postmarket research (960)
Preclinical (2999)
Press Release (25)
Radiopharmaceuticals (63)
Rare diseases (42)
Real estate (1266)
Regulatory (2809)
Research institute (1343)
Resumes & cover letters (23)
Southern California (252)
Startups (1107)
United States (2569)
Vaccines (178)
Weight loss (17)
Date
Today (37)
Last 7 days (145)
Last 30 days (661)
Last 365 days (7690)
2024 (6554)
2023 (9305)
2022 (11516)
2021 (13262)
2020 (12815)
2019 (12169)
2018 (9032)
2017 (8735)
2016 (8918)
2015 (10245)
2014 (7813)
2013 (7576)
2012 (7543)
2011 (7550)
2010 (6765)
Location
Africa (260)
Arizona (34)
Asia (10236)
Australia (2570)
California (664)
Canada (239)
China (51)
Colorado (36)
Connecticut (38)
Europe (27056)
Florida (78)
Georgia (22)
Illinois (88)
Indiana (36)
Japan (18)
Maryland (77)
Massachusetts (405)
Michigan (17)
Minnesota (41)
New Jersey (173)
New York (205)
North Carolina (193)
Northern California (345)
Ohio (45)
Pennsylvania (144)
South America (290)
Southern California (252)
Texas (93)
Washington State (71)
168,480 Results for "yale university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cyduct Diagnostics To Participate at the 10th Annual Yale Innovation Summit
CYduct Diagnostics, Inc. (OTC PINK:CYDX) (“CYduct”, “CYductDX”, or the “Company”), an innovator in precision breast health enabled by non-invasive intraductal platforms, today announced it is pleased to present at the 2024 Yale Innovation Summit, being held from May 29-30 in New Haven, CT.
May 16, 2024
·
4 min read
Press Releases
Yale School of Medicine recognized by NIH for excellence in genetics of rare diseases
September 13, 2024
·
2 min read
Drug Development
Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD
Transcend Therapeutics, a biotechnology company developing rapid-acting treatments for neuropsychiatric diseases, announced receipt of a collaborative grant award with Yale University to support first-of-its-kind preclinical research on methylone – Transcend’s lead compound for the treatment of post-traumatic stress disorder (PTSD).
September 21, 2023
·
2 min read
BioCapital
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
NexImmune, Inc. announces the extension of the research partnership between NexImmune, Yale and JDRF to explore the use of NexImmune’s AIM nanoparticles in combination with an anti-CD3 mAb to tolerize, deplete or modulate diabetes antigen-specific T cells.
October 24, 2023
·
5 min read
Pharm Country
Cognition Therapeutics and Collaborators at Yale and ACTC Announce Oral Late-breaking Presentation on the START Study in Early Alzheimer’s Disease at CTAD
Cognition Therapeutics, Inc. (NASDAQ: CGTX) announced that Christoper van Dyck, M.D., the director of the Yale Alzheimer’s Disease Research Unit and the Yale Alzheimer’s Disease Research Center, is presenting the Phase 2 study design of the company’s ongoing START study in an oral late-breaking session at Clinical Trials on Alzheimer’s Disease (CTAD) conference.
October 27, 2023
·
8 min read
BioMidwest
Epigenetic laboratory TruDiagnostic launches first ever organ-specific aging analysis from Yale-developed SYMPHONYAge algorithms
Marking a milestone development in epigenetic research and clinical health applications, laboratory TruDiagnostic is launching the first ever, epigenetic aging analysis of individual organ systems, using validated and system-specific trained clocks.
June 28, 2024
·
4 min read
Pharm Country
Trevi Therapeutics to Present at Upcoming Yale Innovation Summit 2023
Trevi Therapeutics, Inc. today announced its participation at the upcoming Yale Innovation Summit taking place from May 31 – June 1 at the Yale School of Management.
May 9, 2023
·
5 min read
Business
Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study
Algernon Pharmaceuticals Inc. is pleased to announce that it has entered an Investigator-Initiated Clinical Trial Agreement (“CTA”) with Yale University (“Yale”) for the investigation of multiple intravenous doses of DMT for the treatment of depression.
October 24, 2022
·
4 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Pharm Country
Biohaven Advances Development of the MoDE Platform Technology Licensed From Yale University
Biohaven Ltd. announced advancements in the development of its MoDE extracellular target degrader platform technology licensed from Yale University for various disease indications, including, but not limited to, neurological disorders, cancer, infectious and autoimmune diseases.
October 25, 2022
·
6 min read
1 of 16,848
Next